Collagen Biografts for Tunable Drug Delivery (Record no. 78307)

000 -LEADER
fixed length control field 03626nam a22005535i 4500
001 - CONTROL NUMBER
control field 978-3-030-63817-7
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220801220208.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210131s2021 sz | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9783030638177
-- 978-3-030-63817-7
082 04 - CLASSIFICATION NUMBER
Call Number 610.28
100 1# - AUTHOR NAME
Author Joshi, Rucha.
245 10 - TITLE STATEMENT
Title Collagen Biografts for Tunable Drug Delivery
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2021.
300 ## - PHYSICAL DESCRIPTION
Number of Pages XII, 107 p. 41 illus., 30 illus. in color.
490 1# - SERIES STATEMENT
Series statement SpringerBriefs in Applied Sciences and Technology,
505 0# - FORMATTED CONTENTS NOTE
Remark 2 Introduction -- Creating Tunable Collagen Matrices - An Approach Inspired by In-Vivo Collagen Synthesis and Self-Assembly -- Application of Collagen Fibril Biografts for Enhancing Local Vascularization in an In-Vivo Chick Chorioallantoic Membrane (CAM) Model -- Appendix A: Type I Collagen Based Drug Delivery Formats -- Appendix B: State-of-the-Art Methods of Tuning Collagen Based Molecular Release.
520 ## - SUMMARY, ETC.
Summary, etc This book reviews collagen-based biomaterials that have been applied broadly to tissue engineering and local drug delivery applications and lays out a landscape for developing a multifunctional biograft material from collagen polymers. The book also discusses current shortcomings in collagen based drug delivery opportunities, including poor mechanical properties, rapid proteolytic degradation, and cursory control over physical properties and molecular release profiles. Finally, a review of application of the collagen biograft materials for promoting neovascularization and tissue regeneration is presented, using examples of established in-vivo chicken egg chorioallantoic membrane (CAM) model. Use of heparin for affinity-based vascular endothelial growth factor (VEGF) retention in collagen constructs is also discussed for promoting neovascularization. Reviews state-of-the-art strategies for drug incorporation and retention in collagen ; Covers collagen based material applications for improving vascularization and tissue regeneration; Illustrates how to tailor collagen architecture for soft tissue engineering and controlled drug delivery.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://doi.org/10.1007/978-3-030-63817-7
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBooks
100 1# - AUTHOR NAME
-- (orcid)0000-0002-0456-233X
-- https://orcid.org/0000-0002-0456-233X
264 #1 -
-- Cham :
-- Springer International Publishing :
-- Imprint: Springer,
-- 2021.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomedical engineering.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Regenerative medicine.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Materials.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biotechnology.
650 14 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomedical Engineering and Bioengineering.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Regenerative Medicine and Tissue Engineering.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Materials Engineering.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biotechnology.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
-- 2191-5318
912 ## -
-- ZDB-2-ENG
912 ## -
-- ZDB-2-SXE

No items available.